Becton, Dickinson and Company

NYSE:BDX 주식 보고서

시가총액: US$69.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Becton Dickinson 관리

관리 기준 확인 3/4

Becton Dickinson's CEO는 Tom Polen, Apr2017 에 임명되었습니다 의 임기는 7.33 년입니다. 총 연간 보상은 $ 17.31M, 7.6% 로 구성됩니다. 7.6% 급여 및 92.4% 보너스(회사 주식 및 옵션 포함). 는 $ 13.83M 가치에 해당하는 회사 주식의 0.02% 직접 소유합니다. 13.83M. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 6.8 년입니다.

주요 정보

Tom Polen

최고 경영자

US$17.3m

총 보상

CEO 급여 비율7.6%
CEO 임기7.4yrs
CEO 소유권0.02%
경영진 평균 재임 기간2.8yrs
이사회 평균 재임 기간6.9yrs

최근 관리 업데이트

Recent updates

Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery

Sep 13

Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Aug 06

Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

Jul 16
Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Jun 27
An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

May 24
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

Becton, Dickinson and Company: Stagnating All Along

May 16

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30
Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12
Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05
With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22
Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Mar 20
Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Mar 05
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use

Feb 21

Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test

Feb 08

Becton, Dickinson Q1 2023 Earnings Preview

Feb 01

Becton, Dickinson declares $0.91 dividend

Jan 24

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Jan 09
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod

Jan 09

CEO 보상 분석

Tom Polen 의 보수는 Becton Dickinson 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$1b

Mar 31 2024n/an/a

US$1b

Dec 31 2023n/an/a

US$1b

Sep 30 2023US$17mUS$1m

US$1b

Jun 30 2023n/an/a

US$2b

Mar 31 2023n/an/a

US$2b

Dec 31 2022n/an/a

US$1b

Sep 30 2022US$17mUS$1m

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022n/an/a

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021US$14mUS$1m

US$2b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

US$1b

Dec 31 2020n/an/a

US$2b

Sep 30 2020US$12mUS$952k

US$245m

Jun 30 2020n/an/a

US$786m

Mar 31 2020n/an/a

US$923m

Dec 31 2019n/an/a

US$760m

Sep 30 2019US$6mUS$900k

US$1b

Jun 30 2019n/an/a

US$784m

Mar 31 2019n/an/a

US$926m

Dec 31 2018n/an/a

US$894m

Sep 30 2018US$6mUS$850k

US$159m

Jun 30 2018n/an/a

US$621m

Mar 31 2018n/an/a

-US$99m

Dec 31 2017n/an/a

US$294m

Sep 30 2017US$4mUS$761k

US$1b

보상 대 시장: Tom 의 총 보상 ($USD 17.31M )은 US 시장( $USD 13.17M ).

보상과 수익: Tom 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Tom Polen (51 yo)

7.4yrs

테뉴어

US$17,309,938

보상

Mr. Thomas E. Polen, Jr., also known as Tom, serves as Chief Executive Officer and Director at Becton, Dickinson and Company since January 28, 2020. Mr. Polen has been Director at Walgreens Boots Alliance,...

리더십 팀

이름위치테뉴어보상소유권
Thomas Polen
President7.4yrsUS$17.31m0.020%
$ 14.2m
Christopher DelOrefice
Executive VP & CFO3yrsUS$5.21m0.0044%
$ 3.1m
Shana Neal
Executive VP & Chief People Officer2.4yrsUS$5.89m0.0057%
$ 4.0m
Michael Garrison
Executive VP & President of Medical segment2yrsUS$3.65m0.0019%
$ 1.3m
Thomas Spoerel
Senior VP4.9yrs데이터 없음0.00071%
$ 495.6k
Elizabeth McCombs
Executive VP & Chief Technology Officer3.4yrs데이터 없음데이터 없음
Joseph Smith
Senior VP2.8yrs데이터 없음데이터 없음
Denise Fleming
Executive VP of Technology & Global Services and Chief Information Officer2.7yrs데이터 없음데이터 없음
Greg Rodetis
Head of Investor Relationsless than a year데이터 없음데이터 없음
Michelle Quinn
Executive VP & General Counsel1.6yrs데이터 없음0.0017%
$ 1.2m
Claudia Curtis
Senior VPno data데이터 없음데이터 없음
Carla Burigatto
Senior VP & Chief Communications Officerno data데이터 없음데이터 없음

2.8yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: BDX 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Thomas Polen
President4.7yrsUS$17.31m0.020%
$ 14.2m
Joseph Smith
Senior VP2.8yrs데이터 없음데이터 없음
John DeFord
Co-Chair of Scientific Advisory Board3.3yrs데이터 없음데이터 없음
Robert Eckert
Independent Director8yrsUS$362.77k0.0028%
$ 2.0m
Timothy Ring
Independent Director7.7yrsUS$332.78k0.020%
$ 14.3m
Jeffrey Henderson
Independent Director6.1yrsUS$357.78k0.0019%
$ 1.3m
Christopher Ian Jones
Independent Director14.2yrsUS$362.78k0.0074%
$ 5.2m
Bertram Scott
Lead Independent Director22yrsUS$372.78k0.012%
$ 8.5m
Catherine Burzik
Independent Director11.7yrsUS$357.78k0.0046%
$ 3.2m
William Brown
Independent Director2.6yrsUS$332.78k0.00087%
$ 607.3k
Claire Fraser-Liggett
Member of Scientific Advisory Board & Independent Director17.8yrsUS$340.15k0.0078%
$ 5.5m
Carrie Byington
Independent Director2.9yrsUS$337.78k0.00099%
$ 691.1k

6.9yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: BDX 의 이사회는 경험(평균 재직 기간 6.8 년)으로 간주됩니다.